Asset Allocation & Management Company’s Thermo Fisher Scientific TMO Stock Holding History

Asset Allocation & Management Company’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-468	Closed	-$233K	–	101
2025 Q1	$233K	Hold	468	–	–	0.12%	83
2024 Q4	$243K	Buy	+468	New	+$257K	0.13%	75
2023 Q1	–	Sell	-468	Closed	-$258K	–	117
2022 Q4	$258K	Hold	468	–	–	0.1%	103
2022 Q3	$237K	Buy	+468	New	+$262K	0.1%	103

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Asset Allocation & Management Company's TMO Position: Q2 2025 in Review

Asset Allocation & Management Company sold out of Thermo Fisher Scientific (TMO) in Q2 2025, closing a stake of 468 shares — an estimated $233K sold.

Asset Allocation & Management Company first reported a position in TMO in Q3 2022 and held it in 4 quarters. The position peaked at $258K in Q4 2022. 2,459 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Asset Allocation & Management Company reported no remaining Thermo Fisher Scientific position as of Q2 2025 after selling out during the quarter.
Asset Allocation & Management Company sold 468 Thermo Fisher Scientific shares in Q2 2025, an estimated $233K.
Asset Allocation & Management Company first reported a position in Thermo Fisher Scientific in Q3 2022 and held it in 4 quarters.
Asset Allocation & Management Company's Thermo Fisher Scientific position peaked at $258K in Q4 2022.
2,459 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Asset Allocation & Management Company's 13F filing for Q2 2025, filed 16 Jul 2025.